Trials / Unknown
UnknownNCT00418743
Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)
A Phase II Randomised Trial of Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC), Comparing Oral Combination Chemotherapy (CCNU, Cyclophosphamide, Etoposide) With Intravenous Association Chemotherapy.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 138 (estimated)
- Sponsor
- Groupe Francais De Pneumo-Cancerologie · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine treatment efficacy and tolerability of second-line treatment in patients with small cell lung cancer comparing oral combinaison chemotherapy with intravenous combination chemotherapy.
Detailed description
Determined treatment efficacy and tolerability of second-line treatment in patients with small cell lung cancer comparing oral combinaison chemotherapy with intravenous combination chemotherapy.
Conditions
Timeline
- Start date
- 2005-12-01
- Completion
- 2010-05-01
- First posted
- 2007-01-05
- Last updated
- 2010-03-09
Locations
24 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00418743. Inclusion in this directory is not an endorsement.